Viracta Subsidiary, Inc. of Cardiff, CA, a company, filed a Form D amendment with the SEC on 2010-08-02. The offering totals $16.1M, of which $16.1M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 39 people.
| Name | Role | Location |
|---|---|---|
| Ronald Berenson | Director | Seattle, WA |
| Frederick Dotzler | Director | San Diego, CA |
| Paul Goddard | Director | San Francisco, CA |
| Naheed Misfeldt | Director | San Francisco, CA |
| Wayne Roe | Director | Mountain View, CA |
| Armen Shanafelt | Director | Austin, TX |
| George Stamatoyannopoulos | Director | Seattle, WA |
| James N Woody | Director | Palo Alto, CA |
| Ronald Berenson | Executive Officer | Seattle, WA |
| Mark Handfelt | Executive Officer | Seattle, WA |
| Susan Perrine | Executive Officer | Boston, MA |
| Ronald Berenson | Promoter | Seattle, WA |
| Patrick Soon-Shiong | Director | Colorado Springs, CO |
| Ivor Royston | Director | La Jolla, CA |
| Ivor Royston | Executive Officer | La Jolla, CA |
| Barry Simon | Director | Santa Monica, CA |
| Gur Roshwalb | Director | San Diego, CA |
| MICHAEL HUANG | Director | LEXINGTON, MA |
| Richard Ghalie | Director | Cardiff, CA |
| Daniel Chevallard | Executive Officer | Cardiff, CA |
| Roger Pomerantz | Director | Cardiff, CA |
| Samuel Murphy | Director | Cardiff, CA |
| David Slack | Executive Officer | Cardiff, CA |
| Standish Fleming | Director | Cardiff, CA |
| James Woody | Director | Cardiff, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2021-03-10 | D | $65.0M | $65.0M |
| 2020-12-10 | D | $40.0M | $40.0M |
| 2019-11-05 | D | $25.0M | $16.8M |
| 2019-02-12 | D | $5.7M | $5.7M |
| 2019-02-12 | D/A | $10.7M | $10.7M |
| 2018-12-13 | D | $10.0M | $2.0M |
| 2018-07-02 | D | $8.5M | $2.7M |
| 2017-04-05 | D | $26.9M | $9.9M |
| 2012-04-04 | D | $16.0M | $6.5M |
| 2010-02-01 | D | $12.7M | $6.0M |